Updates from ASCO 2022
Read about HER2-low and HR+ treatment updates, as well as research on Black people’s attitudes about trial participation.
Read about HER2-low and HR+ treatment updates, as well as research on Black people’s attitudes about trial participation.
for past articles or specific information.